Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.

Stephen L ChanFrankie MoPhilip JohnsonLeung LiNelson TangHerbert LoongAnthony Wing-Hung ChanJane KohAnthony T C ChanWinnie Yeo

Published in: Journal of gastroenterology and hepatology (2016)

BALAD score is applicable in the population of hepatitis B virus-related HCC. The combined use of BALAD score and BCLC staging system could help identify more suitable candidates for clinical trial.

Keyphrases

hepatitis b virus
clinical trial
liver failure
open label
pet ct
double blind
drug induced